AUPH SG&A Expense Growth
Aurinia Pharmaceuticals Inc · SG&A Expense Growth
AUPH SG&A Expense Growth
Latest reported-40.83%period ending
AUPH FY SG&A Growth (YoY) (0.00% → -40.83%)
Latest values, visible window
High-resolution chart · PNG
AUPH sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -40.8271% | |
| -11.7968% | |
| -0.6798% | |
| 14.5435% | |
| 76.246% | |
| 335.4553% | |
| 63.3611% | |
| 13.0456% | |
| 73.5438% | |
| 11.2885% | |
| -9.1001% | |
| 208.7655% | |
| -42.8148% | |
| 42.1884% | |
| -16.0096% | |
| -9.4874% | |
| -20.4682% | |
| -20.5268% | |
| -7.7821% | |
| -36.6926% | |
| 24.6218% | |
| -5.7856% | |
| 67.7862% | |
| 62.6363% | |
| 72.2204% | |
| 74.0521% | |
| -25.4931% | |
| 0% |